Ticker Attention Investors: Note: The depositories (CDSL/NSDL), in coordination with SEBI, have upgraded their investor mobile applications to provide a consolidated view of investors’ holdings in securities markets. CDSL: MyEasiApp | NSDL: Speede App Beware of fraudulent Calls, SMS, Emails, WhatsApp & Telegram messages assuring high returns and / or enticing you to invest money in the name of Aditya Birla Money by installing fake App from spurious links. You can download our Elevate App only from Google Play Store or Apple App Store or login to Elevate Web portal. Click Here to know more.

Aditya Birla Money Limited

Aditya Birla Money Limited

TTK Healthcare Ltd

Symbol : TTKHLTCARE | BSE Code : 507747 | Sector : DIVERSIFIED - MEDIUM / SMALL

899.35-8.00 (-0.88%)
13-May-2026 | 12:00
Loading

Market Cap (₹ Cr.)

1,270.81
Today’s High / Low
928.00
892.45
52 Week High / Low
1,398.90
735.00
882.00-16.45 (-1.83%)
13-May-2026 | 12:00
Loading

Market Cap (₹ Cr.)

1,246.30
Today’s High / Low
916.45
882.00
52 Week High / Low
1,402.00
737.00
899.35-8.00 (-0.88%)
13-May-2026 | 12:00

Turnover (₹ Cr.)

47,703,199,137.00
Today’s High / Low
54,325
53,397.60
899.35-8.00 (-0.88%)
13-May-2026 | 12:00

Turnover (₹ Cr.)

958,745,970.00
Today’s High / Low
2
1.75
OVERVIEW
  • Open
  • 928.00
  • Prev. Close
  • 907.35
  • High
  • 928.00
  • Low
  • 892.45
  • Market Cap (₹ Cr.)
  • 1,270.81
  • 52 Week High
  • 1,398.90
  • 52 Week Low
  • 735.00
  • Traded Volume (Lacs)
  • 1,308
  • Traded Value (Cr)
  • Dividend Yield
  • 1.11
  • Face Value
  • 10.00
  • EPS
  • 49.28
  • P/E
  • 18.23
  • Beta (1 year)
  • 1.02
OVERVIEW
  • Open
  • 916.45
  • Prev. Close
  • 898.45
  • High
  • 916.45
  • Low
  • 882.00
  • Market Cap (₹ Cr.)
  • 1,246.30
  • 52 Week High
  • 1,402.00
  • 52 Week Low
  • 737.00
  • Traded Volume (Lacs)
  • 65
  • Traded Value (Cr)
  • Dividend Yield
  • 1.11
  • Face Value
  • 10.00
  • EPS
  • 49.28
  • P/E
  • 18.23
  • Beta (1 year)
OVERVIEW
  • Open
  • 53,750.00
  • Prev. Close
  • 53,721.80
  • High
  • 54,325
  • Low
  • 53,397.60
  • Strike Price
  • 0.00
  • Open Interest(Nos.)
  • 2,332,680.00
  • OI Change %
  • 0.31
  • Volume(Lacs)
  • 0.31
  • Lot Size
  • 30.00
  • Average Price
  • 53,872.57
  • OI Difference
  • 7,320.00
  • Previous OI
  • 2,325,360.00
OVERVIEW
  • Open
  • 2.15
  • Prev. Close
  • 2.65
  • High
  • 2
  • Low
  • 1.75
  • Strike Price
  • 26,900.00
  • Open Interest(Nos.)
  • 47,840.00
  • OI Change %
  • 9.36
  • Volume(Lacs)
  • 9.36
  • Lot Size
  • 65.00
  • Average Price
  • 2.03
  • OI Difference
  • 4,095.00
  • Previous OI
  • 43,745.00
LAST 5 DAYS

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 16.55%

  • 13/05/2026 BSE
    -16.45(-1.83)
    Close Price: ₹ 882.00
    Volume: 65.00

    13-May-2026
  • 13/05/2026 BSE
    -14.45(-1.58)
    Close Price: ₹ 898.45
    Volume: 89.00

    12-May-2026
  • 13/05/2026 BSE
    -17.90(-1.92)
    Close Price: ₹ 912.90
    Volume: 103.00

    11-May-2026
  • 13/05/2026 BSE
    -5.50(-0.59)
    Close Price: ₹ 930.80
    Volume: 28.00

    08-May-2026
  • 13/05/2026 BSE
    3.30(0.35)
    Close Price: ₹ 936.30
    Volume: 48.00

    07-May-2026

1 YEAR RETURN - UNDERPERFORMED THE SENSEX BY 16.55%

  • Stock Absolute
  • -2.68
  • 2.79
  • -26.10
  • -26.03
  • 53.87
  • Returns
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y
  • Sensex Absolute
  • -3.19
  • -2.98
  • -9.55
  • 20.20
  • 53.13
NEWS

TTK Healthcare standalone net profit declines 37.06% in the December 2025 quarter

22-Jan-2026

No Data Available

Net profit of TTK Healthcare declined 37.06% to Rs 10.53 crore in the quarter ended December 2025 as against Rs 16.73 crore during the previous quarter ended December 2024. Sales rose 2.23% to Rs 209.30 crore in the quarter ended December 2025 as against Rs 204.74 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales209.30204.74 2
OPM %3.413.75 -
PBDT23.8824.70 -3
PBT21.6622.59 -4
NP10.5316.73 -37

22
Jan

TTK Healthcare standalone net profit declines 37.06% in the December 2025 quarter



02
Jan

TTK Healthcare announces board meeting date



17
Oct

TTK Healthcare standalone net profit rises 18.55% in the September 2025 quarter



FINANCIAL DATA

In Cr.

Mar 2025Mar 2024Mar 2023
SOURCES OF FUNDS :   
Share Capital 14.1314.1314.13
Reserves Total 1,050.92986.79939.25
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.00
Read More
Mar 2025Mar 2024Mar 2023
INCOME :   
Sales Turnover 801.49752.79725.11
Excise Duty0.000.000.00
Net Sales801.49752.79725.11
Other Income 85.1662.61643.38
Read More
ParticularsDec 2025Sep 2025Jun 2025
Gross Sales 209.30203.57226.43
Excise Duty 000
Net Sales 209.30203.57226.43
Other Operating Income 000
Other Income  17.4319.0117.94
Read More
Category No. Of Shares Percentage (%)
Total Foreign 462271 3.27
Total Institutions 156500 1.11
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 580969 4.11
Total Promoters 10535840 74.56
Total Public & others 2,394,753.00 16.95
Total 100.00 100.00
Read More
CORPORATE ACTIONS
Record Date Ex-Bonus Date Ratio
nodata
No Data Available!!!
Read More
Record Date Split Date Face Value Before Face Value After
nodata
No Data Available!!!
Read More
Read More
ANNOUNCEMENT DATE EX DIVIDEND DATE DIVIDEND (%) DIVIDEND TYPE
23-05-2025 18-07-2025 100 Final
24-05-2024 16-07-2024 100 Final
23-05-2023 18-07-2023 100 Final
23-05-2022 26-07-2022 100 Final
27-05-2021 12-08-2021 60 Final
PREMIUM (₹) RATIO RECORD DATE EX RIGHTS DATE
nodata
No Data Available!!!
Read More
Read More
FROM DATE EX TO DATE AGENDA
03-02-2026 NA Consequent to conclusion of th...
24-01-2026 27-01-2026 The Board of Directors accorde...
22-01-2026 NA TTK Healthcare Ltd-has informe...
26-12-2025 NA Sarayu Thiruvallur Thattai
26-12-2025 NA Late Thiruvallur Thattai Jagan...
COMPANY INFO

TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov '81. The Company is the owner of famous Woodwards Gripewater brand. The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions. It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses.

In 1992, the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance long-term working capital needs, normal capital expenditure, and product promotion.

Products of TTK Healthcare include cardiac care systems, blood management systems, renal care systems, hospital accessories, antibiotics, Woodwards gripe water, animal medicines, etc.

It also has a consumer products and food division manufacturing kiwi shoe polishes, snacks, etc. The company has collaborations with a number of foreign corporations such as London International, Kali-Chemi, Germany; Hatu-ICO, Spain; Nicholas Kiwi, US, etc. The products of the company are exported to the UK, Egypt, the US, Germany, Singapore, Malaysia, Carribean countries, etc.

The Pallavaram plant of the company has been accredited with the ISO 14002 certification by the Bureau of Indian Standards. Also, one of the group companies, TT Maps and Publications was merged with TTK Pharma in 1993.

The company faced some rough weather in Jul.'95 when the MRTPC ordered an inquiry against it for allegedly directing its whole-salers to keep a minimum stock of the company's products and defining their area of operations. During 1996-97, the company has tied up with M/s Mentholatum India Pvt Ltd.

During the year 1999-2000, as a part of the restructuring programme, the paper divison of the company has been disposed off and the merger of TTK Biomed has been approved by the Hon'ble High Court Of Madras with retrospective e

Read More
Get Free Demat Account
Captcha Image